Literature DB >> 18221250

Irritable bowel syndrome aggregates strongly in families: a family-based case-control study.

Y A Saito1, J M Zimmerman, W S Harmsen, M De Andrade, G R Locke, G M Petersen, N J Talley.   

Abstract

Irritable bowel syndrome (IBS) runs in families. Prior family studies surveyed patients inquiring about family history without surveying family members. The stigma associated with IBS may lead relatives to not share information with others,resulting in underestimates of familial aggregation of IBS. The aim of the study was to evaluate the accuracy of patient-report of family history of IBS in cases and controls, and to estimate familial aggregation of IBS using both a case-control and a family-study design. Fifty cases and 53 controls completed symptom questionnaires and provided contact information for first-degree relatives. Questionnaires were mailed to relatives. Relatives were considered to have IBS if they met Rome criteria and did not have an alternate GI diagnosis. Cases and controls identified 573 relatives in their families. A total of 202 (51%) of 396 living relatives participated. The kappa statistics between proband- and relative-reported IBS for case- and control-relatives were 0.27 and 0.04. Cases reported 21%of relatives had IBS; relative-reports showed 37%(P = 0.003). Controls reported 4% of relatives had IBS;relative-reports showed 16% (P = 0.013). Regardless of whether the proband or the relative themselves were the information source, case-relatives were three fold as likely to have IBS than control-relatives (P < 0.05).However, overall rates were higher when data collected from relatives were used. Regardless of approach, strong familial aggregation of IBS was observed. Cases and controls underestimated the frequency of IBS in their relatives and agreement between proband- and relative-report of IBS status was extremely poor, thus emphasizing the need for direct data collection from relatives in IBS family studies.

Entities:  

Mesh:

Year:  2008        PMID: 18221250      PMCID: PMC2873036          DOI: 10.1111/j.1365-2982.2007.1077.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  15 in total

1.  Assessment of functional gastrointestinal disease: the bowel disease questionnaire.

Authors:  N J Talley; S F Phillips; C M Wiltgen; A R Zinsmeister; L J Melton
Journal:  Mayo Clin Proc       Date:  1990-11       Impact factor: 7.616

2.  A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group.

Authors:  S Bellentani; P Baldoni; S Petrella; C Tata; C Armocida; P Marchegiano; G Saccoccio; F Manenti
Journal:  Fam Pract       Date:  1990-12       Impact factor: 2.267

Review 3.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

4.  Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist.

Authors:  V Attanasio; F Andrasik; E B Blanchard; J G Arena
Journal:  J Behav Med       Date:  1984-06

5.  Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.

Authors:  R L Levy; K R Jones; W E Whitehead; S I Feld; N J Talley; L A Corey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

6.  Evidence of a genetic contribution to functional bowel disorder.

Authors:  A Morris-Yates; N J Talley; P M Boyce; S Nandurkar; G Andrews
Journal:  Am J Gastroenterol       Date:  1998-08       Impact factor: 10.864

7.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

8.  Familial aggregation of irritable bowel syndrome: a prospective study.

Authors:  J S Kalantar; G R Locke; A R Zinsmeister; C M Beighley; N J Talley
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

9.  A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome.

Authors:  Y A Saito; G R Locke; J M Zimmerman; G Holtmann; J P Slusser; M de Andrade; G M Petersen; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2007-06       Impact factor: 3.598

10.  Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.

Authors:  P O Vandvik; L Aabakken; P G Farup
Journal:  Scand J Gastroenterol       Date:  2004-05       Impact factor: 2.423

View more
  30 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Familial aggregation of irritable bowel syndrome: a family case-control study.

Authors:  Yuri A Saito; Gloria M Petersen; Joseph J Larson; Elizabeth J Atkinson; Brooke L Fridley; Mariza de Andrade; G Richard Locke; Janice M Zimmerman; Ann E Almazar-Elder; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2010-03-16       Impact factor: 10.864

3.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

Review 4.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

5.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 6.  The brain-gut axis in abdominal pain syndromes.

Authors:  Emeran A Mayer; Kirsten Tillisch
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 7.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 8.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

9.  Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy.

Authors:  Yuri A Saito; Peter R Strege; David J Tester; G Richard Locke; Nicholas J Talley; Cheryl E Bernard; James L Rae; Jonathan C Makielski; Michael J Ackerman; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

10.  From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.

Authors:  Oscar Rodríguez-Fandiño; Joselín Hernández-Ruiz; Max Schmulson
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.